Segantii Capital Management LTD Provention Bio, Inc. Transaction History

Segantii Capital Management LTD

  • $807 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020
SELL
$7.81 - $17.0 $2.23 Million - $4.85 Million
-285,000 Closed
0 $0
Q1 2020

May 08, 2020
BUY
$5.42 - $17.75 $128,454 - $420,675
23,700 Added 9.07%
285,000 $2.62 Million
Q4 2019

Jan 30, 2020
SELL
$5.84 - $14.9 $2.71 Million - $6.9 Million
-463,400 Reduced 63.94%
261,300 $3.89 Million
Q3 2019

Oct 24, 2019
BUY
$6.83 - $13.0 $4.95 Million - $9.42 Million
724,700 New
724,700 $4.95 Million

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Segantii Capital Management LTD Portfolio

Follow Segantii Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Segantii Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Segantii Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email